An interventional study of HIIT and No specific exercise intervention. in Metabolic Dysfunction-Associated Fatty Liver Disease, sponsored by Tang Yida. Not yet recruiting at 5 sites in China. Open to participants aged 35 Years to 65 Years. Per ClinicalTrials.gov, last updated 2025-09-17.
Sponsored by Tang Yida · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 132 studies in Motor Activity with a site in China — 41 open to participants now, 49 under way, 1 of them phase 3. Motor Activity · China.
Among the 132 studies in Motor Activity with a site in China, this one is the 89th largest by planned enrollment of the 113 interventional ones that give a count, is one of 13 that started in 2025, is one of 105 with no phase, reaches primary completion later than 16 of the 48 other live ones, and was the 99th registered.
9,826 studies on the registry are indexed under Motor Activity; 1,911 are open to participants now.
Browse Motor Activity studies →41 of the 132 studies in Motor Activity with a site in China are open now. Recruiting first, the newest first:
Peking University Third Hospital · Sites in China
Ages 35–70
Yang Zhang · Sites in China
Ages 60–79
Shanghai Jiao Tong University School of Medicine · Sites in China
Ages 18–70 · Women only
Peking University People's Hospital · Sites in China
Ages 65+ · Healthy volunteers
Shanghai Zhongshan Hospital · Sites in China
Ages 18+
A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →
Of the 1,207 Motor Activity studies recruiting now, 524 (43%) set no upper age limit and 538 (45%) stop at 75 or younger; 180 take children under 18; 420 take healthy volunteers.
This study: 35 Years to 65 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
132 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 3 · Phase 3 3 · Phase 4 2
First in 2005; this study’s year is marked. 13 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 54 is close to the median of 60 across 8,412 interventional studies indexed under Motor Activity.
Median enrollment 113 across the 113 interventional studies, 221 across the 19 observational. Of the 58 that completed or were terminated, 1 (2%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 132 have an industry lead sponsor. The 10 most frequent:
Tang Yida is the lead sponsor of 2 studies on the registry; 2 are open to participants now.
Tang Yida has 1 study filed under Motor Activity — fewer than ten, so there is no comparison to draw.
18 of the studies in Motor Activity with a site in China that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07738809Capital University of Physical Education and Sports, ChinaEffects of Exercise Intervention on Sleep Quality and Emotional Problems in College Students With Depressive Symptoms | 2026-11 |
| NCT07755995Xu ShuishuiLatin Dance and Psychological Health in Primary School Children | 2026-11-30 |
| NCT07554027Second Affiliated Hospital, School of Medicine, Zhejiang UniversityEffect of Episodic Future Thinking on Promoting Physical Activity Among Older Adults With Motoric Cognitive Risk Syndrome: A Randomized Controlled Trial | 2026-12 |
| NCT07137520Shenzhen Institutes of Advanced Technology ,Chinese Academy of SciencesThe Impact of Various Exercise Intensities on Energy Expenditure Metabolism | 2026-12 |
| NCT06570083Beijing Normal UniversityMobile-Based Intervention to Promote Physical Activity Among the Elderly | 2026-12-30 |
Add all 18 to your calendar (.ics) → With an account.
Among the 132 studies in Motor Activity with a site in China, from their registry updates:
This tab as a report to print or save as PDF → With an account.
High-intensity interval training (HIIT), as an individualized exercise training mode based on cardiopulmonary exercise testing (CPET), is characterized by high-intensity training sessions interspersed with short rest periods. The findings from recent trials suggest that in the management of metabolic dysfunction-associated fatty liver disease (MAFLD), compared with traditional aerobic exercise modes such as moderate-intensity continuous training, HIIT may achieve similar or even better effects in reducing liver fat content, increasing peak oxygen uptake, improving insulin resistance, and lowering blood pressure, despite requiring less time commitment and lower energy expenditure. However, there is currently no consensus regarding the formulation of HIIT exercise protocols.
Based on the lower limits of the current mainstream HIIT intensity, sets, and interval time parameters, this study aims to assess the effectiveness, safety, and feasibility of the current exercise prescription in improving MAFLD.
54 Participants aged 35-65 years with MAFLD will be randomized 1:1 to intervention or control. The intervention group will undertake home-based HIIT four times weekly for 8 weeks. Each session comprises 8 cycles with 30-second bouts at 80% peak VO₂ followed by 60-second recoveries at 50% peak VO₂. The control group do not take any types of exercise interventions. Standard care would be provided for both groups.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Adults age 35\~65 years Nonalcoholic fatty liver diagnosed by abdominal ultrasonography
In conjunction with at least one cardiometabolic risk factor:
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A blood test of average blood sugar over the past two to three months, given as a percentage or in mmol/mol. 6.5% (48 mmol/mol) or more is the usual threshold for diabetes, normally confirmed by a second test.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
A recording of the heart’s electrical activity, taken with stickers on the chest, arms and legs. It takes a few minutes and does not hurt.
HbA1c
A blood test of average blood sugar over the past two to three months, given as a percentage or in mmol/mol. 6.5% (48 mmol/mol) or more is the usual threshold for diabetes, normally confirmed by a second test.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
ECG (electrocardiogram)
A recording of the heart’s electrical activity, taken with stickers on the chest, arms and legs. It takes a few minutes and does not hurt.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Home-based HIIT performed on electric resistance bikes.
Behavioral: HIIT
No specific exercise intervention.
Behavioral: No specific exercise intervention.
Exercise sessions were conducted as telemedically supervised, home-based HIIT performed on electric resistance bikes, with protocols individually tailored. Each HIIT session comprised 8 cycles of alternating 30-second high-intensity intervals (HIT at 80% peakVO₂) and 60-second low-intensity recovery intervals (LIT at 50% peakVO₂). Warm-up and cool-down phases were performed with the bike's resistance set to 0 watts (unloaded pedaling). The total intervention duration was 8 weeks. Received health lifestyle education based on the Prevention and Treatment Guidelines for Metabolic (Non-Alcoholic) Fatty Liver Disease (2024 Edition) and the Dietary Guidelines for Adults with Hyperlipidemia (2023 Edition).Wear smart bracelets 24/7 to monitor daily activity levels, with participants prohibited from engaging in any other systematic exercise training during the intervention period.
The control group will not receive any exercise intervention, and they will be instructed to not take any structured exercise regimens.Received health lifestyle education based on the Prevention and Treatment Guidelines for Metabolic (Non-Alcoholic) Fatty Liver Disease (2024 Edition) and the Dietary Guidelines for Adults with Hyperlipidemia (2023 Edition).Wear smart bracelets 24/7 to monitor daily activity levels, with participants prohibited from engaging in any other systematic exercise training during the intervention period.
Liver fat content (%)
Liver fat content will be measured using MRI-PDFF.
Time frame: Baseline (week 0) , after complete post-training (week 8).
LSM (kPa)
Liver fibrosis will be measured using MRE.
Time frame: Baseline (week 0) , after complete post-training (week 8).
Blood specimen
Lab tests include red blood cell count.
Time frame: Baseline (week 0) , after complete mid-training (week 4), after complete post-training (week 8).
Blood specimen
Lab tests include hematocrit.
Time frame: Baseline (week 0) , after complete mid-training (week 4), after complete post-training (week 8).
Blood specimen
Lab tests include hemoglobin count.
Time frame: Baseline (week 0) , after complete mid-training (week 4), after complete post-training (week 8).
Blood specimen
Lab tests include testosterone.
Time frame: Baseline (week 0) , after complete mid-training (week 4), after complete post-training (week 8).
Blood specimen
Lab tests include cortisol.
Time frame: Baseline (week 0) , after complete mid-training (week 4), after complete post-training (week 8).
Blood specimen
Lab tests include creatine kinase.
Time frame: Baseline (week 0) , after complete mid-training (week 4), after complete post-training (week 8).
Blood specimen
Lab tests include blood urea.
Time frame: Baseline (week 0) , after complete mid-training (week 4), after complete post-training (week 8).
Blood specimen
Lab tests include alanine aminotransferase.
Time frame: Baseline (week 0) , after complete mid-training (week 4), after complete post-training (week 8).
Blood specimen
Lab tests include aspartate aminotransferase.
Time frame: Baseline (week 0) , after complete mid-training (week 4), after complete post-training (week 8).
Blood specimen
Lab tests include lactic acid
Time frame: After first time and complete of mid-training (week 4), after first time and complete of post-training (week 8).
Exercise Feasibility
The implementation status of the home-based exercise prescription, including training frequency per week, average pedal frequency of the high-intensity exercise on the resistance bike, and average pedal frequency of the low-intensity exercise on the resistance bike
Time frame: Every week after complete training from week 1 to week 8.
LSM (kPa)
Liver fibrosis will be measured using Fibrotouch@.
Time frame: Baseline (week 0) , after complete post-training (week 8).
Peak VO2
Peak VO2 is assessed through CPET, using a maximal graded treadmill test based on the Chinese expert consensus on the standardized clinical application of CPET.
Time frame: Baseline (week 0) , after complete post-training (week 8).
BMI
Weight (kg) is measured with digital weighing scale. Height (cm) is measured with a portable stadiometer. BMI is calculated as weight in kilograms divided by the square of height in meters
Time frame: Baseline (week 0) , after complete post-training (week 8).
Brog score
The Borg Subjective Fatigue Scale (Borg) would be tested after each session
Time frame: After complete mid-training (week 4) , after complete post-training (week 8).
Exercise Feasibility
The proportion of subjects leaving group during the preparation period and early termination of the trial
Time frame: From baseline (week 0) to after complete post-training (week 8).
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Sep 2025; primary completion for Mar 2026, 6 months later.
Of 5,176 non-industry interventional studies with no phase under Motor Activity, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 36. This study's planned 6 months is below that.
Counting every sponsor, half of 5,236 studies reached it within 17 months; a quarter within 7 and three quarters within 36.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Tang Yida